[Differences in the management and prognosis of patients with non-ST segment elevation acute coronary syndrome according to the department of initial admission].
OBJECTIVE
To assess the influence of the department of initial admission on the hospital management and 3-month prognosis of patients with non-ST elevation acute coronary syndromes.


METHODS
The data for the 4115 patients admitted to 18 hospitals in the PEPA study were compared according to the department of initial admission.


RESULTS
Twenty-six percent of the patients were admitted to the coronary care unit, 53% to the cardiology department, 9% to the internal medicine department, and 12% were discharged from the emergency ward. The baseline risk profile was high in patients admitted to the coronary care unit and decreased progressively in patients admitted to the cardiology, internal medicine and emergency departments (P<.00001). The intensity of medical management was progressively lower in these departments, but not in parallel to their different baseline lower risk profile. Beta blockers were administered to 50%, 45%, 27% and 21% of the patients, respectively; an exercise test was performed in 34%, 44%, 35% and 12%; coronary angiography in 46%, 34%, 19% and 0%; and coronary revascularization in 22%, 12%, 9% and 0% (P<.00001). The 3-month incidence of mortality or myocardial infarction was 12.2%, 6.4%, 8.7% and 3.8%, respectively (P<.00001), differences that became nonsignificant after adjustment for risk profile on admission.


CONCLUSIONS
Patients with non-ST elevation acute coronary syndrome admitted to the coronary care unit or cardiology department have a profile of higher risk on admission than patients admitted to the internal medicine department. Also, these patients more frequently receive pharmacological treatments and diagnostic and therapeutic procedures of proven efficacy but not in a manner that parallels their different risk profile on admission. However, these differences in the intensity of in-hospital management do not seem to lead to differences in the 3-month prognosis.
Bosch
Xavier
X
Institut de Malalties Cardiovasculars, Hospital Clínic. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Departamento de Medicina, Universidad de Barcelona, Barcelona, España. xbosch@medicina.ub.es
Verbal
Fernando
F
López de Sá
Esteban
E
Miranda-Guardiola
Faustino
F
Bórquez
Emiliano
E
Bethencourt
Armando
A
López-Sendón
José L
JL
D000208:Acute Disease; D000368:Aged; D000789:Angina, Unstable / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006748:Hospital Departments; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000503:physiopathology / Q000628:therapy*; D010343:Patient Admission; D011379:Prognosis; D013577:Syndrome